As the European cannabis conference season gets started, industry experts, lawmakers, regulators and business owners are facing greater mainstream scrutiny...
Scrutiny of the UK’s medical cannabis industry has rarely, if ever, been so acute since it was legalised in 2018. ...
Few conditions in the field of medical cannabis are backed by such adamant patient conviction, but as little clinical data...
More than 70 international speakers and over 1000 delegates set to convene on London next month for policy debates, high-level...
As the European medical cannabis market has developed, expanded and matured over the last half-decade, Portugal has played a critical...
Canadian cannabis exports totalled CA$51.6 million in February 2026 across the three main cannabis HS codes tracked in export data,...
The global legal cannabis industry is no longer an emerging market, but a maturing one with established regulatory frameworks, institutional...
Over the last few weeks, the UK’s medical cannabis industry has been written about in The Times, The Guardian, the...
The second quarter of 2026 has brought tentative signs of stabilisation to a cannabis sector that spent much of 2025...
The Irish government has appointed a public health academic to chair a formal review of its now five-year-old Medical Cannabis...
US Medicare patients have now been given access to cannabidiol (CBD) products through a landmark federal pilot scheme, helping boost...
As the UK’s medical cannabis industry continues to come under fierce scrutiny from the country’s mainstream media, James Duckenfield, CEO...
Zurich’s municipal parliament has voted to extend its flagship adult-use cannabis pilot, Züri Can, by a further two years to...
On the second anniversary of Germany’s landmark Cannabis Act (CanG) coming into force, the most comprehensive data and analysis of...
Written by Ben Stevens & Sarah Sinclair A new campaign is calling for urgent regulatory changes to how medical cannabis...
The UK CBD industry’s long and hard-fought battle to become the first in the world to receive official regulatory approval...
The White House’s commitment to push through rescheduling has been challenged by a Democratic Senator, who has demanded answers on...
Six weeks after the US Food and Drug Administration (FDA) failed to meet its 90-day deadline to clarify which cannabinoids...
